Genpact Ltd [G] stock is trading at $46.17, up 0.79%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The G shares have gain 4.17% over the last week, with a monthly amount glided 9.15%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Genpact Ltd [NYSE: G] stock has seen the most recent analyst activity on January 21, 2025, when Jefferies upgraded its rating to a Buy and also boosted its price target to $55 from $44. Previously, JP Morgan upgraded its rating to Neutral on July 17, 2024, and dropped its price target to $40. On January 30, 2024, Mizuho initiated with a Neutral rating and assigned a price target of $40 on the stock. Robert W. Baird downgraded its rating to a Neutral but stick to its price target of $38 on December 15, 2023. JP Morgan downgraded its rating to a Underweight but $40 remained the price target by the analyst firm on August 22, 2023. Citigroup downgraded its rating to Neutral for this stock on July 18, 2023, and downed its price target to $42. In a note dated December 15, 2022, JP Morgan downgraded an Neutral rating on this stock and revised its target price from $55 to $50.
Genpact Ltd [G] stock has fluctuated between $30.23 and $47.98 over the past year. Currently, Wall Street analysts expect the stock to reach $43.67 within the next 12 months. Genpact Ltd [NYSE: G] shares were valued at $46.17 at the most recent close of the market. An investor can expect a potential drop of -5.41% based on the average G price forecast.
Analyzing the G fundamentals
Genpact Ltd [NYSE:G] reported sales of 4.66B for the trailing twelve months, which represents a growth of 6.56%. Gross Profit Margin for this corporation currently stands at 0.35% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.29 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.77.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.73 points at the first support level, and at 45.28 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.61, and for the 2nd resistance point, it is at 47.04.
Ratios To Look Out For
For context, Genpact Ltd’s Current Ratio is 1.85. Further, the Quick Ratio stands at 1.85, while the Cash Ratio is 0.79. Considering the valuation of this stock, the price to sales ratio is 1.75, the price to book ratio is 3.40 and price to earnings (TTM) ratio is 12.67.
Transactions by insiders
Recent insider trading involved Mehta Piyush, Senior Vice President and CHRO, that happened on Jan 10 ’25 when 12000.0 shares were sold. President and CEO, Kalra Balkrishan completed a deal on Dec 13 ’24 to sell 13600.0 shares. Meanwhile, Officer BALKRISHAN KALRA bought 13600.0 shares on Dec 13 ’24.
